Genbio

Founded in 1945, Alcon Laboratories is a pharmaceutical company that develops and manufactures a variety of health care products throughout the world. It maintains operations in more than 75 countries, including the United States, Canada and Africa, as well as the Middle East. The company sells and markets a range of surgical equipment and pharmaceutical and consumer vision care products. It is engaged in the research and development of medicines for the treatment of glaucoma, diabetic retinopathy, macular degeneration, inflammation, eye infections, allergies and artificial tears. The company s products include contact lens, eye drops, antioxidant vitamins, vitreoretinal systems, sutures, needles and knives. It supplies products under the INFINITI, ACRYSOF, DISCOVISC, CUSTOM-PAK, CONSTELLATION, SYSTANE and PATADAY brands. The company offers distribution and technical support services. It offers services to health care professionals. Alcon Laboratories is owned by Nestl .

Photon Technology International Inc. designs, manufactures and markets proprietary electro-optical instruments. Founded in 1983, the company became a publicly held company in 1987. Leading laboratories around the world use its products for medical research, health care, industrial process, quality control, environmental science and other applications. The company offers a wide range of products, such as QuantaMaster 30, QuantaMaster 40, LaserStrobe, RatioMaster, TimeMaster LED TM-20 and more. Its customer base is spread across the world, which includes companies, such as Albany Medical College-Division of Neurosurgery, Alcon Laboratories, Columbia University-Department of Pharmacy, Food and Drug Administration, Dalhousie University- Department of Physiology, Kabi Pharmacia AB, Sandoz Institute and more.

Cholestech provides diagnostic tools and information to health care practitioners in more than 35 countries worldwide. It offers diagnostic testing for cholesterol, lipids, blood glucose, liver enzymes and glycemic control. The company also provides risk assessment and therapeutic monitoring solutions for heart disease and diabetes. Its products, Cholestech LDX and Cholestech GDX systems, are approved by the Food & Drug Administration (FDA) to be used for monitoring the progress of patient therapy. Its Cholestech GDX system, a hemoglobin A1C testing system is comprised of GDX analyzer, single-use test cartridges and related accessories that indicate blood sugar control over last two and three months. Cholestech sells products throughout the United States, as well as Europe, Asia, South America and Australia through a network of distributors.